Presentation of Selected Topics - The World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy)

Home

Welcome Note

Chair Persons

Presentation of Selected Topics

Pre-Congress Symposia

Presentation of Selected Topics

Please click on the hyperlinks below to view Powerpoint presentations:

Hypoglycemia

Long acting analogues/pumps – the answer to the barrier

M. Phillip, Israel

Post-Prandial Glucose under Crossfire

The value of measuring and treating post-prandial hyperglycaemia – Evidence from prospective studies

M. Hanefeld, Germany

Alternatives for Injected Insulin

Do we need alternative routes of insulin administration (inhaled insulin) in Type 2 diabetes?
S. Efendic, Sweden

Novel Treatments to Cure Type 2 Diabetes Mellitus (T2DM)

Pathophysiology of T2DM: is there a fundamental incretin defect?
J. J. Holts, Denmark

Normoglycemia and Cardiovascular Outcome

Does insulin treatment during and after acute stress have advantages beyond the lowering effect of blood glucose?
K. Strojek, Poland

Continuous Glucose Monitoring (GCM)

Do we need alternatives for insulin administration? Can long-acting analogues replace pump therapy?

J. Pickup, UK

Different Forms of Insulin

Combined therapy - is there any advantage?
M. Riddle, USA

Insulin analogues versus pump therapy in Type 2 diabetes? Pump therapy

E. M. Renard, France

Target Blood Pressure

Aggressive lowering of blood pressure in diabetes: the diastolic cost

N. Stern, Israel

Role of Hyperglycemia in Cardiovascular Outcomes

Behavioral aspects of postprandial self-monitoring blood glucose (SMBG) in patients with T2DM: Real world strategies for encouraging its everyday use
W. Polonsky, USA

Metabolic Syndrome

Treatment beyond lifestyle for the metabolic syndrome: Prefer existing therapy (Metformin, PPAR gama/alpha, Orlistat)

F. Giorgino, Italy

Accuracy of Blood Pressure Measurements in Hypertension

Ambulatory versus self-home-monitoring for the assessment of out-of-office blood pressure
M. Bursztyn, Israel

The role of physical activity in the prevention and management of hypertension and obesity
R. Fagard, Belgium

Anti-Hypertension Drugs in Obese Diabetic Patients

Is there a need for new RAAS blockers in diabetic hypertension?
D. N. Mueller, Germany

Accuracy of Blood Pressure Measurements in Hypertension

Clinical and prognostic value of isolated office and masked hypertension?
D. L. Clement, Belgium

Excessive Hypertension

Should peri-operative hypertension lead to postponment of surgery?
S. J. Howell, UK

Weight Loss

Surgical treatment of obesity – when and how? The surgeon’s perspective

J. M. Morton, USA

Effect of Obesity and Diabetes on Internal Target Organs

Abdominal fat and sleep apnea
G. Pillar, Israel

Controlling Obesity

Glucocorticoid generation in the adernals and adipose tissue in obesity
B. R. Walker, UK

Childhood and Adolescent Obesity and Diabetes

The metabolically healthy obese: Should they be treated? Is there a way to identify diabetes - prone individuals? PCOS patients - is this a special subset of patients?
D. Pettitt, USA

Obesity and Pregnancy Outcome

Reproductive outcome in women with body weight disturbanses

Z. Shoham, Israel

Diabetes and Chronic Pancreatitis

Prevalence and clinical relevance of exocrine pancreatic insufficiency
in diabetes mellitus
P. Hardt, Germany